MCK
75
-2
IPG
45
-4
VIX
32
-11
GME
63
3
AKAM
39
7
SYK
44
4
MS
58
5
KMI
85
2
ORLY
64
2
HBI
64
2
PPL
75
-2
WU
44
-4
AMP
61
4
PCG
64
2
ISRG
62
3
R
62
2
AAL
27
3
OXY
48
2
PH
70
4
MCHP
46
4
MCK
75
-2
IPG
45
-4
VIX
32
-11
GME
63
3
AKAM
39
7
SYK
44
4
MS
58
5
KMI
85
2
ORLY
64
2
HBI
64
2
PPL
75
-2
WU
44
-4
AMP
61
4
PCG
64
2
ISRG
62
3
R
62
2
AAL
27
3
OXY
48
2
PH
70
4
MCHP
46
4
Financhill
Back

ArrowMark Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
52

BANX
ArrowMark Financial

Last Price:
$20.83
Seasonality Move:
7.69%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Buy
52
ArrowMark Financial (BANX) is a Buy

Is ArrowMark Financial a Buy, Sell or Hold?

  • The current ArrowMark Financial [BANX] share price is $20.84. The Score for BANX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BANX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BANX Stock Price Chart

What is ArrowMark Financial's stock price today?

  • The ArrowMark Financial share price today is $20.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BANX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 44.18 Sell
Chaikin Money Flow: 6198 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.91 - 21.25) Sell
Bollinger Bands (100): (20.64 - 21.2) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

BANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.02 Sell
20-day SMA: 21.07 Sell
50-day SMA: 21.06 Sell
200-day SMA: 20.27 Buy
8-day EMA: 20.99 Sell
20-day EMA: 21.05 Sell
50-day EMA: 21.03 Sell
200-day EMA: 20.31 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

ArrowMark Financial Earnings Growth & BANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

ArrowMark Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):